Rocky Mountain Cancer Centers, Site #191 — Boulder, Colorado

Rocky Mountain Cancer Centers, Site #191 is a clinical research site located in Boulder, Colorado, United States 80303.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers, Site #191 has participated in 1 clinical trials.

Therapeutic areas: Chronic Myeloid Leukemia.

Sponsors: Ariad Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers, Site #191?

Rocky Mountain Cancer Centers, Site #191 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers, Site #191 conducted?

Rocky Mountain Cancer Centers, Site #191 has 1 clinical trials on record. Their work covers Chronic Myeloid Leukemia.

Is Rocky Mountain Cancer Centers, Site #191 accredited by Crixeo Health?

Rocky Mountain Cancer Centers, Site #191 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rocky Mountain Cancer Centers, Site #191?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.